OneMedNet Corp appointed Mr. Aaron Green as new CEO

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


Departure of Executive Officer


On March 27, 2024, Paul J. Casey, Chief, Chief Executive Officer of the Company, notified the Company of his intention to retire as Chief Executive Officer of the Company effective March 29, 2024. Mr. Casey will continue to serve as a member of the Board of Directors (the "Board") of the Company. In connection with Mr. Casey's service on the Advisory Board of the Company, the Board approved a Stock Option Grant (the "Option Grant") providing for the grant of 147,000 five-year options exercisable at $1.00 per share adviser to Mr. Casey.


Departure of Director


Also on March 27, 2024, Scott Holbrook, a member of the Board of the Company and a member of the Company's Audit Committee, notified the Company of his intention to retire from the Company's Board effective March 29, 2024. Mr. Holbrook's notice of retirement did not advise the Company of any disagreement with the Company on any matter relating to its accounting, operations, policies or practices.


Appointment of Executive Officer


Effective March 29, 2024, the Board appointed Mr. Aaron Green, to serve as Chief Executive Officer of the Company to fill the vacancy created by the retirement of Paul Casey. Mr. Green brings is a seasoned public company executive and healthcare IT leader, with more than 20 years of experience including an impressive track record of driving growth, leading business transformations and creating shareholder value. As President and CEO, Green will lead all facets of OneMedNet's business involving its iRWD™ offering, including R&D, product, strategy, and sales across global markets. Under Mr. Green's leadership, the Company has successfully added four new large strategic partners which nearly doubles OneMedNet's clinical data Network in 2024 to-date, and has already contributed to growth in booking of 15% year-over-year. Mr. Green holds a Bachelor of Science in Biochemistry from the University of Victoria, British Columbia, a Systems Analyst Diploma from Royal Roads University, British Columbia, and an Executive MBA from the Wharton School of Business.


Appointment of Director


Effective March 29, 2024, the Board appointed Mr. Aaron Green, to serve as a member of the Board to fill the vacancy created by the retirement of Scott Holbrook and appointed Board member, Dr. Thomas Kosasa, to serve on the Company's Audit Committee, also to fill the vacancy created by the retirement of Scott Holbrook.


There are no arrangements or understandings between Mr. Green and any other person, in each case, pursuant to which Mr. Green was appointed to serve on the Board. There are no family relationships between Mr. Green and any other director or executive officer of the Company and none are currently proposed, that would require disclosure under Item 404(a) of Regulation S-K.


In accordance with the Company's customary practice, the Company will also enter into its standard form of indemnification agreement with Mr. Green. The description of the indemnification arrangements with OneMedNet's directors and officers is contained in the Proxy Statement/Prospectus declared effective by the SEC on September 22, 2023 in the section titled "Management of the Company Following the Business Combination - Limitation on Liability and Indemnification of Officers and Directors" and "Management of the Company Following the Business Combination - Limitation on Liability and Indemnification Matters."